Skip to main content
. 2011 Jul 7;16(9):1280–1291. doi: 10.1634/theoncologist.2010-0349

Figure 3.

Figure 3.

Receiver operating characteristic analysis for BCL2L12 and BCL2 mRNA expression. BCL2L12 expression (–-–) was found to distinguish successfully chronic lymphocytic leukemia patients from healthy controls. Furthermore, the discriminatory power of BCL2 expression (---) was significantly strengthened when combined with BCL2L12 expression (—). Abbreviation: AUC, areas under the receiver operating characteristic curves.